A recent paper titled “The 2024 Assisi think tank on breast cancer: Focus on the use of a tumour bed boost after breast conserving therapy” was published in The Breast Journal by Meritxell Arenas et al.
Authors: Meritxell Arenas, Yasemin Bölükbaşı, Liesbeth Boersma, Cynthia Aristei, Philip Poortmans et al.
Elisabetta Bonzano, Radiation Oncologist at IRCCS San Matteo Polyclinic Foundation, shared this article on X, commenting:
“The 2024 Assisi think tank on breast cancer: Focus on the use of a tumour bed boost after breast-conserving therapy
- The Fifth Assisi Think Tank Meeting on breast cancer discussed tumour bed boost.
- Tumour bed boost can reduce local recurrence by up to 50 % but does not impact on overall survival.
- If the estimated absolute reduction in local recurrence exceeds 3 % at 10 years, a boost should be suggested.
- Balancing tumour bed boost benefits with potential side effects is key to achieving optimal outcomes for patients.
- Future research should identify patients who can avoid the boost and refine tumour bed boost volumes for more precise treatments.”
More posts featuring Elisabetta Bonzano.